Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Caruso, Anita ^a   Vigna, Cristina ^a   Marozzo, Bruna ^a   Sega, Fabio M ^a   Sperduti, Isabella ^a   Cognetti, Francesco ^a   Savarese, Antonella ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL EVALUATION; COMPARATIVE STUDY; COMPUTER MODEL; CONTROLLED STUDY; DEMOGRAPHY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC COUNSELING; HETEROZYGOTE; HIGH RISK POPULATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBJECTIVE RISK; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; SUBJECTIVE RISK; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; OVARY TUMOR; PERCEPTION; PSYCHOLOGICAL ASPECT; RISK;

ADULT; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PERCEPTION; RISK; RISK ASSESSMENT; YOUNG ADULT;

EID: 74849110509     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-157     Document Type: Article

References (41)

1. Women's receptivity to testing for a genetic susceptibility to breast cancer. H Chaliki S Loader JC Levenkron W Logan-Young WJ Hall PT Rowley, Am J Public Health 1995 85 1133 1135 10.2105/AJPH.85.8-Pt-1.1133 7625512
2. Risk communications in genetic testing for cancer susceptibility. RT Croyle C Lerman, J Natl Cancer Inst 1999 25 59 66
3. Why do women attend familial breast cancer clinics? K Brain J Gray P Norman E Parsons A Clarke C Rogers R Mansel P Harper, J Med Genet 2000 37 197 202 10.1136/jmg.37.3.197 10699056
4. Adherence and psychological adjustment among women at high risk for breast cancer. C Lerman M Shwartz, Breast Cancer Res Treat 1993 28 145 155 10.1007/BF00666427 8173067 (Pubitemid 24056086)
5. Psychological counseling strategies for women at increased risk of breast cancer. KM Kash JC Holland MP Osbourne DG Miller, J Natl Cancer Inst 1995 17 73 79
6. The impact of genetic counseling on risk perception and mental health in women with a family history of breast cancer. M Watson S Lloyd J Davidson L Meyer R Eeles S Ebbs V Murday, Br J Cancer 1999 79 868 74 10.1038/sj.bjc.6690139 10070883
7. Long-term psychological impact of carrying a BRCA1/BRCA2 mutation and prophylactic surgery: A 5-year follow-up study. I Van Oostrom H Meijers-Heijboer LN Lodder HJ Duivenvoorden AR van Gool C Seynaeve CA van der Meer JG Klijn BN van Geel CW Burger JW Wladimiroff A Tibben, J Clin Oncol 2003 21 3867 3874 10.1200/JCO.2003.10.100 14551306
8. Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. AR Bradbury CN Ibe JJ Dignam SA Cummings M Verp MA White G Artioli L Dudlicek OI Olopade, Genet Med 2008 10 161 6 10.1097/GIM.0b013e318163487d 18344704
9. Illness perception and distress in women at increased risk of breast cancer. G Rees A Fry A Cull S Sutton, Psychol Health 2004 19 749 765 10.1080/08870440412331279764 (Pubitemid 40004499)
10. A literature review of the psychological impact of genetic testing on breast cancer patients. KJ Schlich-Bakker HFJ ten Kroode MGEM Ausems, Patient Educ Couns 2006 60 13 20 10.1016/j.pec.2005.08.012 (Pubitemid 43832070)
11. Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations. K Kelly H Leventhal M Marvin D Toppmeyer J Much J Dermody J Baran M Schwalb, Genet Test 2004 8 139 47 15345111
12. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations. KM Kelly L Senter H Leventhal G Ozakinci K Porter, Patient Educ Couns 2008 70 135 142 10.1016/j.pec.2007.09.007 17988821
13. The effect of experimental knowledge on construction of risk perception in hereditary breast/ovarian cancer. L D'Agincourt-Canning, J Genet Couns 2005 14 55 69 10.1007/s10897-005-1500-0 15789156
14. Predictors of perceived breast cancer risk and relation between perceived risk and breast cancer screening: a meta-analytic review. MC Katapodi KA Lee NC Facione MJ Dodd, Prev Med 2004 39 388 402 10.1016/j.ypmed.2003.11.012 (Pubitemid 38327011)
15. Gail Model breast cancer risk components are poor predictors of risk perception and screening behaviour. MB Daly C Lerman E Ross MD Schwartz CB Sands A Masny, Breast Cancer Res Treat 1996 41 59 70 10.1007/BF01807037 8932877
16. Lay understanding of familial risk of common chronic disease: A systematic review and synthesis of qualitative research. FM Walter J Emery D Braithwaite TM Marteau, Ann Fam Med 2004 2 583 594 10.1370/afm.242 15576545
17. Spiritual coping, family history and perceived risk for breast cancer-can we make sense of it? JM Quillin DK McClish RM Jones K Burruss JN Bodurtha, J Genet Couns 2006 15 449 460 10.1007/s10897-006-9037-4 17013546
18. Perception of breast cancer risk and surveillance behaviours of women with family history of breast cancer: a brief report on a Spanish cohort. F Gil I Mendez A Sirgo G Llort I Blanco L Cortes-Funes, Psychooncology 2003 12 821 827 10.1002/pon.704 14681955
19. The withdrawal from oncogenetic counseling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample. A Caruso C Vigna G Maggi FM Sega F Cognetti A Savarese, J Exp Clin Cancer Res 2008 27 75 82 10.1186/1756-9966-27-75 19025627
20. BRCAPRO validation, sensitivity of genetic testing of BRCA1/2, and prevalence of other breast cancer susceptibility genes. DA Berry Jr Iversen ES DF Gudbjartsson EH Hiller JE Garber BN Peshkin C Lerman P Watson HT Lynch SG Hilsenbeck WS Rubinstein KS Hughes G Parmigiani, J Clin Oncol 2002 20 2701 2712 10.1200/JCO.2002.05.121 12039933
21. Modelling risk of breast cancer and decisions about genetic testing. G Parmigiani DA Berry O Aguilar, Am J Hum Genet 1998 62 145 148 10.1086/301670 9443863
22. Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal. M Federico A Maiorana L Mangone D Turchetti B Canossi L Cortesi R Romagnoli V Silingardi, Breast Cancer Res Treat 1999 55 213 221 10.1023/A:1006192230332 10517166
23. Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience. L Cortesi D Turchetti I Marchi A Fracca B Canossi B Rachele R Silvia PA Rita T Pietro F Massimo, BMC Cancer 2006 17 210 10.1186/1471-2407-6-210 (Pubitemid 44382758)
24. Information and awareness of diagnosis and progression of cancer in adult and elderly cancer patients Tumori. A Caruso B Di Francesco P Pugliese V Cinanni A Corlito, J Exp Clini Oncology 2000 86 199 203
25. Breast Cancer and Distress Resulting from Magnetic Resonance Imaging (MRI): the impact of a psychological intervention of emotional and informative support. A Caruso L Bongiorno I Vallini P Russo F Tomao ML Grandinetti, J Exp Clin Cancer Res 2006 25 499 505 17310840
26. Effects of Individualized Breast Cancer Risk Counseling: a randomized trial. C Lerman E Lustbader B Rimer, J Natl Cancer Inst 1995 87 286 292 10.1093/jnci/87.4.286 7707420
27. Cancer Gene Software (Version 4.3) (computer software). D Ehus, Dallas, TX: UT Southwestern Medical Center at Dallas 2006
28. Probability of carrying a mutation of breast-ovarian cancer gene BRCA 1 based on family history. DA Berry G Parmigiani J Sanchez J Schildkraut E Winer, J Natl Cancer Inst 1997 89 227 237 10.1093/jnci/89.3.227 9017003
29. Sequence analysis of BRCA1 and BRCA2: correlations of mutations with family history and ovarian cancer risk. TS Frank SA Manley OI Olopade S Cummings JE Garber B Bernhardt K Antman D Russo ME Wood L Mullineau C Isaacs B Peshkin S Buys V Venne PT Rowley S Loader K Offit M Robson H Hampel D Brener EP Winer S Clark B Weber LC Strong A Thomas, et al. J Clin Oncol 1998 16 2417 2425 9667259
30. BRCA 2 germ-line mutations in male breast cancer cases and breast cancer families. FJ Couch LM Farid ML DeShano SV Tavtigian K Calzone L Campeau Y Peng B Bogden Q Chen S Neuhausen D Shattuck-Eidens AK Godwin M Daly DM Radford S Sedlacek J Rommens J Simard J Garber S Merajver BL Weber, Nat Genet 1996 13 123 125 10.1038/ng0596-123 8673091 (Pubitemid 126528243)
31. The Hospital Anxiety and Depression Scale. AS Zigmond RP Snaith, Acta Psychiatr Scand 1983 67 361 370 10.1111/j.1600-0447.1983.tb09716.x 6880820
32. Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. M Costantini M Musso P Viterbori F Bonci L Del Mastro O Garrone M Venturini G Morasso, Support Care Cancer 1999 7 121 127 10.1007/s005200050241 10335929
33. Attitudes knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. LG Bluman BK Rimer DA Berry N Borstelmann JD Iglehart K Regan J Schildkraut EP Winer, J Clin Oncol 1999 17 1999 104 10561250
34. A coefficient of agreement for nominal scales. J Cohen, Educ Psychol Meas 1960 20 37 46 10.1177/001316446002000104
35. The measurement of observer agreement for categorical data. JR Landis GG Koch, Biometrics 1977 33 159 174 10.2307/2529310 843571
36. Predictive testing for BRCA 1/2: attributes, risk perception and management in a multi-centre clinical cohort. C Foster DG Evans R Eeles D Eccles S Ashley L Brooks R Davidson J Mackay PJ Morrison M Watson, Br J Cancer 2002 86 1209 1216 10.1038/sj.bjc.6600253 11953874
37. Psychological Impact Collaborative Group. Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. B Meiser PN Butow AL Barratt V Schnieden M Gattas J Kirk C Gaff G Suthers K Tucker Psychological Impact Collaborative Group, Patient Educ Couns 2001 44 215 225 10.1016/S0738-3991(00)00191-9 11553422
38. Perception of risk in women with a family history of breast cancer. DG Evans LD Burnell P Hopwood A Howell, Br J Cancer 1993 67 612 614 8439512
39. A systematic review of perceived risk, psychological and behavioural impacts of genetic testing. JT Heshka C Palleschi H Howley B Wilson PS Wells, Genet Med 2008 10 19 32 10.1097/GIM.0b013e31815f524f 18197053
40. Distress and family functioning in oncogenetic counseling for hereditary and familial breast and/or ovarian cancers. C Condello R Gesuita M Pensabene I Spagnoletti I Capuano C Baldi F Carle A Contegiacomo, J Genet Couns 2007 16 625 634 10.1007/s10897-007-9102-7 17701329
41. Psychological side effects of breast cancer screening. C Lerman B Trock BK Rimer C Jepson D Brody A Boyce, Health Psychol 1991 10 259 67 10.1037/0278-6133.10.4.259 1915212